Abstract:

56 patients with sinusitis in benign neoplasms participated in the studies. The positive effect of the immunomodulator polyoxidonium on the clinical course and indicators of local and general immunity of patients with sinusitis with benign neoplasms of the nose and paranasal sinuses has been studied, the drug also increases the effectiveness of treatment, reduces the length of stay of patients in the hospital, reduces relapses of inflammatory and tumor processes.